2022 ESC/ERS-Leitlinien zur Diagnostik und Therapie der pulmonalen Hypertonie

Severe Pulmonary Hypertension in COPD

(2022) Gabor Kovacs et al.   CHEST

Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study

(2022) Luca Valerio et al.   EUROPEAN HEART JOURNAL

Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial

(2022) Theresa-Marie Dachs et al.   EUROPEAN HEART JOURNAL

Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis

(2022) Marius M Hoeper et al.   Lancet Respiratory Medicine

Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study

(2022) Xavier Jaïs et al.   Lancet Respiratory Medicine

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2022) Marc Humbert et al.   EUROPEAN HEART JOURNAL

Effects of remote haemodynamic‐guided heart failure management in patients with different subtypes of pulmonary hypertension: insights from the MEMS‐HF study

(2022) Birgit Assmus et al.   EUROPEAN JOURNAL OF HEART FAILURE

Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis

(2022) Stephan Rosenkranz et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Diagnosing heart failure with preserved ejection fraction with pulmonary vascular disease

(2022) Micha T Maeder   HEART

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

(2021) Aaron Waxman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Elevated pulmonary vascular resistance predicts mortality in COPD patients

(2021) Katarina Zeder et al.   EUROPEAN RESPIRATORY JOURNAL

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

(2021) Marius M Hoeper et al.   Lancet Respiratory Medicine

2021 ESC/EACTS Guidelines for the management of valvular heart disease

(2021) Alec Vahanian et al.   EUROPEAN HEART JOURNAL

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2021) Theresa A McDonagh et al.   EUROPEAN HEART JOURNAL

Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry

(2021) Karen M. Olsson et al.   EUROPEAN RESPIRATORY JOURNAL

The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study

(2021) Stephan Rosenkranz et al.   EUROPEAN JOURNAL OF HEART FAILURE

External validation of a refined 4-strata risk assessment score from the French pulmonary hypertension Registry

(2021) Athénaïs Boucly et al.   EUROPEAN RESPIRATORY JOURNAL

Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension

(2021) Kelly M. Chin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure

(2020) Stephan Rosenkranz et al.   CIRCULATION

Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure

(2020) David M. Shavelle et al.   Circulation-Heart Failure

Pulmonary artery pressure‐guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS E uropean M onitoring S tudy for H eart F ailure ( MEMS‐HF )

(2020) Christiane E. Angermann et al.   EUROPEAN JOURNAL OF HEART FAILURE

Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study

(2020) Bradley A Maron et al.   Lancet Respiratory Medicine

ERS Statement on Chronic Thromboembolic Pulmonary Hypertension

(2020) Marion Delcroix et al.   EUROPEAN RESPIRATORY JOURNAL

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

(2019) Stavros V Konstantinides et al.   EUROPEAN HEART JOURNAL

PULMONARY ARTERIAL HYPERTENSION PATIENTS WITH AND WITHOUT CARDIOVASCULAR RISK FACTORS: RESULTS FROM THE AMBITION TRIAL

(2019) Vallerie V. McLaughlin et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study

(2019) Steven D Nathan et al.   Lancet Respiratory Medicine

Association of Mild Echocardiographic Pulmonary Hypertension With Mortality and Right Ventricular Function

(2019) Jessica H. Huston et al.   JAMA Cardiology

Macitentan in pulmonary hypertension due to left ventricular dysfunction

(2018) Jean-Luc Vachiéry et al.   EUROPEAN RESPIRATORY JOURNAL

Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction

(2018) Rebecca R. Vanderpool et al.   JAMA Cardiology

Chronic thromboembolic pulmonary hypertension

(2018) Nick H. Kim et al.   EUROPEAN RESPIRATORY JOURNAL

Pulmonary hypertension in chronic lung disease and hypoxia

(2018) Steven D. Nathan et al.   EUROPEAN RESPIRATORY JOURNAL

Pulmonary hypertension due to left heart disease

(2018) Jean-Luc Vachiéry et al.   EUROPEAN RESPIRATORY JOURNAL

A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension

(2017) David Kylhammar et al.   EUROPEAN HEART JOURNAL

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

(2017) Marius M. Hoeper et al.   EUROPEAN RESPIRATORY JOURNAL

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

(2017) Athénaïs Boucly et al.   EUROPEAN RESPIRATORY JOURNAL

Pulmonary Hypertension in Heart Failure

(2017) Marco Guazzi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking ProgramCLINICAL PERSPECTIVE

(2016) Bradley A. Maron et al.   CIRCULATION

Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension

(2016) Christian F. Opitz et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial

(2016) William T Abraham et al.   LANCET

A global view of pulmonary hypertension

(2016) Marius M Hoeper et al.   Lancet Respiratory Medicine

Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial

(2015) Elke S. Hoendermis et al.   EUROPEAN HEART JOURNAL

Left ventricular heart failure and pulmonary hypertension

(2015) Stephan Rosenkranz et al.   EUROPEAN HEART JOURNAL

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN HEART JOURNAL

Selexipag for the Treatment of Pulmonary Arterial Hypertension

(2015) Olivier Sitbon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

(2015) Nazzareno Galiè et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction

(2011) Marco Guazzi et al.   CIRCULATION

Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review

(2009) G. Kovacs et al.   EUROPEAN RESPIRATORY JOURNAL